HNO International Narrows Q1 Loss 97% to $182,069 Despite Zero Revenue
HNO International, a Nevada-incorporated company, reported a net loss of $182,069 for the quarter ending January 31, 2026, a 97% improvement from the $5.46 million loss in the prior-year period. The company generated no revenue in either quarter.
HNO International, Inc., a Nevada-incorporated company, posted a net loss of $182,069 for the three months ending January 31, 2026, sharply narrowing from a $5.46 million loss in the same quarter a year earlier. The company reported no revenue in either period. Read more earnings reports.
Operating expenses fell to $187,559 in the latest quarter from $5.45 million in the year-ago quarter, driving the improvement in operating loss to $182,069 from $5.46 million. The prior-year quarter included significantly higher operating expenses that were not repeated in the current period.
Cash and cash equivalents stood at $81,494 as of January 31, 2026, up from $9,525 at the end of October 2025. The company raised $197,500 from financing activities during the quarter, partially offset by $125,531 used in operations. Accounts receivable dropped to zero from $332,669 at the prior quarter-end.
Total assets declined to $1.39 million as of January 31, 2026, from $1.73 million at October 31, 2025. Property, plant and equipment decreased to $1.26 million from $1.32 million over the same period. Depreciation and amortization for the quarter totaled $65,217, up from $54,449 in the year-ago quarter.
The company remained in a negative equity position, with total stockholders' deficit reaching $1.70 million as of January 31, 2026, compared to a $1.63 million deficit at the prior quarter-end. Retained deficit expanded to $52.23 million from $52.05 million. Total liabilities fell to $3.09 million from $3.36 million, with accounts payable declining to $378,729 from $715,236.
Basic and diluted loss per share was less than $0.01 for the quarter ending January 31, 2026, compared to $0.02 per share in the year-ago period. Weighted average shares outstanding decreased to 101.4 million from 340.7 million in the prior-year quarter. Common shares outstanding as of January 31, 2026 totaled 101.8 million.
| Financial Metric | Q1 FY2026 (Jan 31, 2026) | Q1 FY2025 (Jan 31, 2025) |
|---|---|---|
| Total Revenue | $0 | $0 |
| Operating Expenses | $187,559 | $5,454,461 |
| Operating Loss | ($182,069) | ($5,461,393) |
| Net Loss | ($182,069) | ($5,461,393) |
| Cash & Cash Equivalents | $81,494 | $47,900 |
| Total Assets | $1,389,564 | N/A |
| Total Liabilities | $3,086,637 | N/A |
| Stockholders' Deficit | ($1,697,073) | ($1,751,227) |